Rivaroxaban

Company: HangZhou HuiSheng Biotech Pharmaceutical Co., Ltd
Country: China (Mainland)
Business Type: Hangzhou Huisheng Biotech Pharmaceutical Co.,Ltd
Market: The Middle East,Europea,Russia,and South America and US market
Founded Year: 2002
Contact: Tibi Teng

Product sourcing details

Packaging: 25kg/drum

Supplier: HangZhou HuiSheng Biotech Pharmaceutical Co., Ltd

Purchasing information

Minimum order: 1
Lead time: 15 Days

Please confirm with the supplier: Model / reference, Key specifications / compatibility, Samples, Export markets, Supply capacity.

Rivaroxaban is a pure (S)-enantiomer. It is an odorless, non-hygroscopic, white to yellowish powder. Rivaroxaban is only slightly soluble in organic solvents (e.g., acetone, polyethylene glycol 400) and is practically insoluble in water and aqueous media.
Rivaroxaban, a FXa inhibitor, is the active ingredient in XARELTO Tablets. XARELTO a kind of orally anticoagulant drug which is used for the prevention of blood clots. Rivaroxaban takes effect through competitively inhibiting free and clot bound factor Xa, which is needed to activate prothrombin (factor II) to thrombin (factor IIa). The later is a serine protease that is required to activate fibrinogen to fibrin, which is the loose meshwork that completes the clotting process.